Trisalus Life Sciences Stock Cash And Equivalents
| TLSIW Stock | 0.91 0.09 9.00% |
TriSalus Life Sciences fundamentals help investors to digest information that contributes to TriSalus Life's financial success or failures. It also enables traders to predict the movement of TriSalus Stock. The fundamental analysis module provides a way to measure TriSalus Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to TriSalus Life stock.
TriSalus |
TriSalus Life Sciences Company Cash And Equivalents Analysis
TriSalus Life's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
TriSalus Cash And Equivalents Driver Correlations
Understanding the fundamental principles of building solid financial models for TriSalus Life is extremely important. It helps to project a fair market value of TriSalus Stock properly, considering its historical fundamentals such as Cash And Equivalents. Since TriSalus Life's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of TriSalus Life's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of TriSalus Life's interrelated accounts and indicators.
Click cells to compare fundamentals
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
| Competition |
In accordance with the recently published financial statements, TriSalus Life Sciences has 0.0 in Cash And Equivalents. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and 100.0% lower than that of the Health Care industry. The cash and equivalents for all United States stocks is 100.0% higher than that of the company.
TriSalus Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses TriSalus Life's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of TriSalus Life could also be used in its relative valuation, which is a method of valuing TriSalus Life by comparing valuation metrics of similar companies.TriSalus Life is currently under evaluation in cash and equivalents category among its peers.
TriSalus Fundamentals
| Return On Asset | -1.33 | ||||
| Profit Margin | (2.20) % | ||||
| Operating Margin | (1.11) % | ||||
| Number Of Shares Shorted | 42 | ||||
| Revenue | 18.51 M | ||||
| EBITDA | (51.7 M) | ||||
| Net Income | (59.04 M) | ||||
| Total Debt | 51.66 M | ||||
| Book Value Per Share | (0.98) X | ||||
| Cash Flow From Operations | (50.05 M) | ||||
| Number Of Employees | 107 | ||||
| Beta | 0.5 | ||||
| Total Asset | 25.73 M | ||||
| Retained Earnings | (248.38 M) | ||||
| Working Capital | 6.17 M | ||||
| Net Asset | 25.73 M |
About TriSalus Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze TriSalus Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of TriSalus Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of TriSalus Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for TriSalus Stock Analysis
When running TriSalus Life's price analysis, check to measure TriSalus Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TriSalus Life is operating at the current time. Most of TriSalus Life's value examination focuses on studying past and present price action to predict the probability of TriSalus Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TriSalus Life's price. Additionally, you may evaluate how the addition of TriSalus Life to your portfolios can decrease your overall portfolio volatility.